The Institute for Peptide Therapy is an emerging European body convening clinicians, researchers and educators around peer exchange, professional education, clinical governance and the future of therapeutics. It will support the forthcoming Journal for Peptide Therapy, a monthly publication addressing clinically relevant advances from around the world.
Independence statement: The Institute is independent of medicinal-product manufacturers, marketing-authorisation holders, compounders, pharmacies and distributors. It receives no remuneration, referral fees, commissions or other financial benefit contingent upon the prescribing, purchasing or use of any medicinal product or peptide.
Welcome
Our remit
A considered space for clinicians and researchers to convene, compare practice and learn from one another.
Structured learning resources and continuing professional development for qualified practitioners.
Frameworks, standards and reflective tools that support safe, accountable and ethical practice.
Curating literature, supporting investigators and convening dialogue around emerging evidence.
A long-view forum for the scientific, regulatory and societal questions shaping the field.
A monthly editorial review of clinically relevant developments in peptide therapy, published under the Institute.
Education pathway
A structured postgraduate education pathway in therapeutic peptides, for healthcare professionals seeking an evidence-based understanding of one of the fastest-evolving areas of modern medicine. Programmes are organised around professional development — scientific integrity, clinical reasoning and the responsible governance of emerging therapies — rather than around individual compounds.
All programmes are delivered in English and suitable for an international audience. Additional language editions may follow.
Foundations in biology, pharmacology and pharmaceutical science
The scientific foundations of therapeutic peptides, without clinical implementation. Suitable for healthcare professionals, scientists, pharmacists, nurses, researchers and students wishing to understand peptide biology from first principles.
Clinical foundations and evidence-based reasoning
The Clinical Gateway module: the why and how peptides have moved into clinical practice. Rather than focusing on individual compounds, participants learn how experienced clinicians evaluate emerging therapies when the evidence is evolving.
A focused short-domain certificate exploring obesity, metabolic syndrome, insulin resistance, incretin biology and emerging metabolic therapies through current scientific evidence and clinical reasoning.
Register interest to be notified when enrolment opens.
Age-related anabolic decline, sarcopenia, muscle preservation and the physiology of healthy ageing.
The biology of tissue healing, musculoskeletal recovery and regenerative mechanisms, examined through current evidence and clinical reasoning.
Immune signalling, immunosenescence, inflammatory regulation and host defence — examined through current evidence and clinical reasoning.
Biological ageing science, cellular senescence, longevity biology and the responsible evaluation of evidence in an unusually hype-prone field.
Neuroplasticity, cognition, mood, sleep, neuroprotection and the careful evaluation of emerging neurological evidence.
Clinical integration across domains
The Institute's most comprehensive educational programme. Participants complete the full sequence of foundation modules, clinical domains, governance training and integration assessment to develop a professional understanding of therapeutic peptides within contemporary healthcare. The programme explores the use of these therapies in an educational, non-promotional context.
Staying current as the evidence evolves
Learning in this field never stands still. The Institute will regularly release advanced online Masterclasses examining important developments in peptide science and clinical research.
Educational philosophy
Presenting evidence honestly, including its strengths and limitations.
Developing structured approaches to evaluating emerging therapies.
Emphasising governance, ethics and responsible professional practice.
Peptide science continues to evolve and requires continual critical appraisal.
Our programmes are educational in nature. They are designed to improve scientific understanding and professional knowledge. They do not provide prescribing advice or recommend the use of any specific medicinal product. Clinical decisions remain the responsibility of individual healthcare practitioners practising within their professional scope and applicable national laws.
What our students told us
A selection of anonymised comments drawn from end-of-course feedback surveys. They reflect the experience of clinicians and researchers who have completed our early programmes.
“Fabulous course.”
— J.J.
“Excellent coverage of peptide essentials.”
— B.G.
“Nothing to add—it was very informative.”
— T.D.
“As a new clinician in this field, I found it very helpful. The case studies really helped translate the knowledge into clinical presentations.”
— T.M.
“The case presentations were extremely educational and reinforced a practical approach to patient care.”
— P.D.
“Thanks for a great course.”
— L.J.
Summary from survey feedback
Healthcare practitioners consistently described the course as highly relevant to clinical practice.
Students valued the emphasis on peer-reviewed evidence and practical clinical reasoning.
Many participants commented that the platform was easy to navigate and the course straightforward to complete.
The most common request was more case studies, reflecting strong engagement and a desire for even more clinical application.
Several students requested ongoing access to updated research, demonstrating continued interest beyond course completion.
Enquiries
For general, academic, editorial or professional enquiries, please use the form. A formal contact channel will be announced in due course; messages received here will be reviewed by the Institute.
Please do not include patient-identifiable information or requests for clinical advice.